On 07 February 2017
Jubilant Life Sciences announced that a meeting of the Board of Directors of the Company will be held on 07 February 2017, inter alia, to consider Unaudited Financial Results of the Company for the quarter ended 31 December 2016 (Q3).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
